InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the full record of transactions filed by Atlas Venture Fund X, LP. Insider active across 2 companies, notably Kymera Therapeutics, Inc.. In total, 10 reports have been recorded. Activity tracked since 17 June 2026. The latest transaction was disclosed on 4 September 2026 (Notice of proposed sale (Form 144)). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 条申报中的 10 条
Atlas Venture Fund X, LP is a declarant and a shareholder of Kymera Therapeutics, Inc. (XNAS). The record shows 8 filings in total, with recent filings from 2026-06-17 to 2026-06-29, all related to sales, for a combined amount of EUR 135176887 across the sampled filings, and the modal transaction nature is Notice of proposed sale (Form 144).